These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 30586495)
1. Cost variation and savings opportunities in the Oncology Care Model. Baumgardner J; Shahabi A; Zacker C; Lakdawalla D Am J Manag Care; 2018 Dec; 24(12):618-623. PubMed ID: 30586495 [TBL] [Abstract][Full Text] [Related]
2. Greater Spending Associated with Improved Survival for Some Cancers in OCM-Defined Episodes. Baumgardner J; Shahabi A; Linthicum M; Vine S; Zacker C; Lakdawalla D J Manag Care Spec Pharm; 2018 Jun; 24(6):504-513. PubMed ID: 29799330 [TBL] [Abstract][Full Text] [Related]
3. Share of Oncology Versus Nononcology Spending in Episodes Defined by the Centers for Medicare & Medicaid Services Oncology Care Model. Baumgardner JR; Shahabi A; Linthicum MT; Zacker C; Lakdawalla DN J Oncol Pract; 2018 Nov; 14(11):e699-e710. PubMed ID: 30423271 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of Practice Patterns Among Oncologists Participating in the Oncology Care Model. Walker B; Frytak J; Hayes J; Neubauer M; Robert N; Wilfong L JAMA Netw Open; 2020 May; 3(5):e205165. PubMed ID: 32421185 [TBL] [Abstract][Full Text] [Related]
5. Where Are the Opportunities for Reducing Health Care Spending Within Alternative Payment Models? Rocque GB; Williams CP; Kenzik KM; Jackson BE; Halilova KI; Sullivan MM; Rocconi RP; Azuero A; Kvale EA; Huh WK; Partridge EE; Pisu M J Oncol Pract; 2018 Jun; 14(6):e375-e383. PubMed ID: 28981388 [TBL] [Abstract][Full Text] [Related]
6. Area-level variations in cancer care and outcomes. Keating NL; Landrum MB; Lamont EB; Bozeman SR; McNeil BJ Med Care; 2012 May; 50(5):366-73. PubMed ID: 22437623 [TBL] [Abstract][Full Text] [Related]
7. What drives variation in spending for breast cancer patients within geographic regions? Sinaiko AD; Chien AT; Hassett MJ; Kakani P; Rodin D; Meyers DJ; Fraile B; Rosenthal MB; Landrum MB Health Serv Res; 2019 Feb; 54(1):97-105. PubMed ID: 30318592 [TBL] [Abstract][Full Text] [Related]
8. Regional variation in spending and survival for older adults with advanced cancer. Brooks GA; Li L; Sharma DB; Weeks JC; Hassett MJ; Yabroff KR; Schrag D J Natl Cancer Inst; 2013 May; 105(9):634-42. PubMed ID: 23482657 [TBL] [Abstract][Full Text] [Related]
9. Association Between a National Insurer's Pay-for-Performance Program for Oncology and Changes in Prescribing of Evidence-Based Cancer Drugs and Spending. Bekelman JE; Gupta A; Fishman E; Debono D; Fisch MJ; Liu Y; Sylwestrzak G; Barron J; Navathe AS J Clin Oncol; 2020 Dec; 38(34):4055-4063. PubMed ID: 33021865 [TBL] [Abstract][Full Text] [Related]
10. High-Cost Patients and Preventable Spending: A Population-Based Study. de Oliveira C; Cheng J; Chan K; Earle CC; Krahn M; Mittmann N J Natl Compr Canc Netw; 2020 Jan; 18(1):23-31. PubMed ID: 31910386 [TBL] [Abstract][Full Text] [Related]
11. The Role of Patient Factors, Cancer Characteristics, and Treatment Patterns in the Cost of Care for Medicare Beneficiaries with Breast Cancer. Xu X; Herrin J; Soulos PR; Saraf A; Roberts KB; Killelea BK; Wang SY; Long JB; Wang R; Ma X; Gross CP Health Serv Res; 2016 Feb; 51(1):167-86. PubMed ID: 26119176 [TBL] [Abstract][Full Text] [Related]
12. Contribution of preventable acute care spending to total spending for high-cost Medicare patients. Joynt KE; Gawande AA; Orav EJ; Jha AK JAMA; 2013 Jun; 309(24):2572-8. PubMed ID: 23797716 [TBL] [Abstract][Full Text] [Related]
13. Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective. Sagar B; Lin YS; Castel LD J Med Econ; 2017 Oct; 20(10):1018-1023. PubMed ID: 28581874 [TBL] [Abstract][Full Text] [Related]
14. Linking Costs and Survival in the Treatment of Older Adults With Chronic Myeloid Leukemia: An Analysis of SEER-Medicare Data From 1995 to 2007. Lin PJ; Winn AN; Parsons SK; Neumann PJ; Weiss ES; Cohen JT Med Care; 2016 Apr; 54(4):380-5. PubMed ID: 26759984 [TBL] [Abstract][Full Text] [Related]
15. Opportunities for Savings in Risk Arrangements for Oncologic Care. Landon BE; Lam MB; Landrum MB; McWilliams JM; Meneades L; Wright AA; Keating NL JAMA Health Forum; 2023 Sep; 4(9):e233124. PubMed ID: 37713209 [TBL] [Abstract][Full Text] [Related]
16. Documenting the benefits and cost savings of a large multistate cancer pathway program from a payer's perspective. Kreys ED; Koeller JM J Oncol Pract; 2013 Sep; 9(5):e241-7. PubMed ID: 23943896 [TBL] [Abstract][Full Text] [Related]
17. Variation in Physician Spending and Association With Patient Outcomes. Tsugawa Y; Jha AK; Newhouse JP; Zaslavsky AM; Jena AB JAMA Intern Med; 2017 May; 177(5):675-682. PubMed ID: 28288254 [TBL] [Abstract][Full Text] [Related]
18. Dartmouth Atlas Area-Level Estimates of End-of-Life Expenditures: How Well Do They Reflect Expenditures for Prospectively Identified Advanced Lung Cancer Patients? Keating NL; Landrum MB; Huskamp HA; Kouri EM; Prigerson HG; Schrag D; Maciejewski PK; Hornbrook MC; Haggstrom DA Health Serv Res; 2016 Aug; 51(4):1584-94. PubMed ID: 26799913 [TBL] [Abstract][Full Text] [Related]
19. Considerations in the Care of Non-Small-Cell Lung Cancer: The Value Imperative. Kelly R; Houseknecht S Oncology (Williston Park); 2018 Nov; 32(11):534-40. PubMed ID: 30474101 [TBL] [Abstract][Full Text] [Related]
20. Modeling Episode-Based Payments for Cancer Using Commercial Claims Data. Polson M; Lord T; Evangelatos T; Kangethe A; Speicher LC; Barrientos S; Zacker C J Manag Care Spec Pharm; 2019 Feb; 25(2):235-245. PubMed ID: 30698092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]